Gene expression profiles of human endometrial cancer samples using a cDNA-expression array technique: Assessment of an analysis method

British Journal of Cancer

Volumn 83, Issue 2, 2000, Pages 246-251

  Smid Koopman, E ^a   Blok, L J ^b   Chadha Ajwani, S ^a   Helmerhorst, T J M ^a   Brinkmann, A O ^b   Huikeshoven, F J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

cDNA expression array; Endometrial cancer; Genes

Indexed keywords

COMPLEMENTARY DNA; CYCLIN D1; DECORIN; RNA; TISSUE INHIBITOR OF METALLOPROTEINASE 3;

ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DATA ANALYSIS; DEVICE; DISEASE COURSE; ENDOMETRIUM; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; REGRESSION ANALYSIS; TECHNIQUE; TUMOR;

EID: 0034126944     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.2000.1238     Document Type: Article

References (22)

1. Blok LJ, Grossmann ME, Perry JE and Tindall DJ (1995) Characterization of an early growth response gene, which encodes a zinc finger transcription factor potentially involved in cell cycle regulation. Mol Endocrinol 9: 1610-1620
2. +-ATPase in androgen-dependent and androgen-independent prostate cancer. Br J Cancer 81: 28-36
3. Chang GTG, Blok LJ, Steenbeek M, Veldscholte J, van Weerden WM, van Steenbrugge GJ and Brinkmann AO (1997) Differentially expressed genes in androgen-dependent and androgen-independent prostate carcinomas. Cancer Res 57: 4075-4081
4. Chen Y, Martinez LA, LaCava M, Coghlan L and Conti CJ (1998) Increased cell growth and tumorigenicity in human prostate LNCaP cells by overexpression to cyclin D1 Oncogene 16: 1913-1920
5. Fearon ER and Vogelstein BA (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759-767
6. Hilsenbeck SG, Friedrichs WE, Schiff R, O'Connell P, Hansen RK, Osborne CK and Fuqua SAW. (1999). Statistical analysis of array expression data as applied to the problem of tamoxifen resistance. J Natl Cancer Inst 91: 453-459
7. Hoch RV, Thompson DA, Baker RJ and Wiegel RJ (1999) GATA-3 is expressed in association with estrogen receptor in breast cancer. Int J Cancer 84: 122-128
8. Iozzo RV, Chakrani F, Perrotti D, McQuillan DJ, Skorski T, Calabretta B and Eichstetter I (1999) Cooperative action of germ-line mutations in decorin and p53 accelerates lymphoma tumorigenesis. Proc Natl Acad USA 96: 3092-3097
9. Kaiser A, Brembeck FH, Marschall Z, Wiedenmann B and Rosewicz S (1999) Fra-1: a novel target for retinoid action. FEBS Letters 448: 45-48
10. Knudson AG (1993) All in the (cancer) family. Nat Genet 5: 103-104
11. Kugler A (1999) Matrix metalloproteinases and their inhibitors. Anticancer Res 19: 1589-1592
12. Lentz SS (1994) Advanced and recurrent endometrial carcinoma: hormonal therapy. Semin Oncol 21: 100-106
13. Mikuta JJ (1993) International Federation of Gynecology and Obstetrics staging of endometrial cancer 1988. Cancer 71: 1460-1463
14. Rhee CH, Hess K, Jabbur J, Ruiz M, Yang Y, Chen S, Chenchik A, Fuller GN and Zhang W (1999) cDNA expression array reveals heterogeneous gene expression profiles in three glioblastoma cell lines. Oncogem 18: 2711-2717
15. Rose PG (1996) Endometrial carcinoma. New Engl J Med 335: 640-649
16. Russell A, Thompson MA, Hendly J, Trute L, Armes J and Germain D (1999) Cyclin D1 and D3 associate with the SCF complex and are coordinately elevated in breast cancer. Oncogene 18: 1983-1991
17. Sato H, Kida Y, Mai M, Endo Y, Sasaki T, Tanaka J and Seiki M (1992) Expression of genes encoding type IV collagen-degrading metalloproteinases and tissue inhibitors of metalloproteinases in various human tumor cells. Oncogene 7: 77-83
18. Schottenfeld D (1995) Epidemiology of endometrial neoplasia. J Cell Biochem 23: 151-159
19. Shim C, Zhang W, Rhee CH and Lee JH (1998) Profiling of differentially expressed genes in human primary cervical cancer by complementary DNA expression array. Clin Cancer Res 4: 3045-3050
20. Stander M, Naumann U, Wick W and Weller M (1999) Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth. Cell Tissue Res 296: 221-227
21. Tong W and Pollard JW (1999) Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E-and cyclin A-cdk2 kinase activation, and cell proliferation in uterine epithelial cells in mice. Mol Cell Biol 19: 2251-2264
22. Zwijsen RM, Wientjes E, Klompmaker R, van der Sman J, Bernards R and Michalides RJ (1997). CDK-independent activation of estrogen receptor by cyclin D1. Cell 88: 405-415